Lv1
20 积分 2026-04-24 加入
Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia
12小时前
待确认
Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer
12小时前
已完结
Advances in RAS Therapeutics for Pancreatic Cancer
1个月前
已完结
The molecular glue CLEO4-88 inhibits the ACAA1 thiolase by induced binding to GID4
2个月前
已完结
Development of a clinically viable MRGPRX4 inverse agonist for cholestatic itch treatment
2个月前
已完结
皖公网安备34019202002308
